Trade Summary

2 days ago, Fromkin Andrew J., serving as Dir at Immunovant, Inc. (IMVT), sold 221,951 shares at $33.51 per share, for a total transaction value of $7,438,111.20. Following this transaction, Fromkin Andrew J. now holds 74,382 shares of IMVT.

This sale represents a 74.90% decrease in Fromkin Andrew J.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 28, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 29, 2026 at 4:04 PM ET, 1 day after the trade was made.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.